Literature DB >> 7076809

Simultaneous measurement of 3,5-diiodothyronine and 3,5,3'-triiodothyronine turnover kinetics in euthyroid hyperthyroid, and hypothyroid subjects.

J Faber, C Kirkegaard, I B Lumholtz, K Siersbaek-Nielsen, T Friis.   

Abstract

Simultaneous kinetic studies of 3,5-diiodothyronine (3,5-T2) and T3 were performed in 15 healthy controls (8 men and 7 women), 7 hyperthyroid patients (2 men and 5 women), and 6 hypothyroid women using the single injection, noncompartmental approach. The serum concentrations (picomoles per liter), MCRs (liters . day-1 . (70 kg)-1), and production rates (PRs; nmol . day-1 . (70 kg)-1) of 3,5-T2 in healthy men and women were (mean +/- SD): 100 +/- 23 vs. 80 +/- 23 (P = NS), 59 +/- 31 vs. 123 +/- 58 (P less than 0.025), and 5.6 +/- 1.9 vs. 9.1 +/- 2.6 (P less than 0.02). The conversion rate (CR) of T3 to 3,5-T2 was 12.0 +/- 3.8% in men compared to 18.5 +/- 3.7% in women (P less than 0.01). Serum 3,5-T2 levels in five mildly hyperthyroid women were elevated to 123 +/- 33 pmol/liter (P less than 0.05), whereas the MCR and PR were unchanged. However, two hyperthyroid men with more pronounced elevation of serum T3 had enhanced PRs (26.9 and 23.9 nmol . day-1 . (70 kg)-1). The CR in hyperthyroid women was significantly reduced to 5.6 +/- 2.9% (P less than 0.001). The serum levels, MCR, and PR of 3,5-T2 in hypothyroid women were: 58 +/- 25 pmol/liter (P = NS), 71 +/- 52 liters . day-1 . (70 kg)-1 (P = NS), and 3.4 +/- 2.4 nmol . day-1 . (70 kg)-1 (P less than 0.005). The CR was enhanced to 34.8 +/- 15.7% (P less than 0.05). Our data demonstrate that in euthyroid subjects, approximately 15% of T3 is deiodinated to 3,5-T2, and this 5'-deiodination of T3 is influenced by thyroid function.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7076809     DOI: 10.1210/jcem-55-1-8

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

1.  Translating pharmacological findings from hypothyroid rodents to euthyroid humans: is there a functional role of endogenous 3,5-T2?

Authors:  Maik Pietzner; Ina Lehmphul; Nele Friedrich; Claudia Schurmann; Till Ittermann; Marcus Dörr; Matthias Nauck; René Laqua; Uwe Völker; Georg Brabant; Henry Völzke; Josef Köhrle; Georg Homuth; Henri Wallaschofski
Journal:  Thyroid       Date:  2014-11-24       Impact factor: 6.568

2.  Rapid stimulation of hepatic oxygen consumption by 3,5-di-iodo-L-thyronine.

Authors:  C Horst; H Rokos; H J Seitz
Journal:  Biochem J       Date:  1989-08-01       Impact factor: 3.857

3.  Thyroid hormone reduces cholesterol via a non-LDL receptor-mediated pathway.

Authors:  Ira J Goldberg; Li-Shin Huang; Lesley A Huggins; Shuiqing Yu; Prabhakara R Nagareddy; Thomas S Scanlan; Joel R Ehrenkranz
Journal:  Endocrinology       Date:  2012-09-04       Impact factor: 4.736

4.  Urinary metabolomics reveals glycemic and coffee associated signatures of thyroid function in two population-based cohorts.

Authors:  Nele Friedrich; Maik Pietzner; Claire Cannet; Betina H Thuesen; Torben Hansen; Henri Wallaschofski; Niels Grarup; Tea Skaaby; Kathrin Budde; Oluf Pedersen; Matthias Nauck; Allan Linneberg
Journal:  PLoS One       Date:  2017-03-02       Impact factor: 3.240

Review 5.  3,5-Diiodothyronine: A Novel Thyroid Hormone Metabolite and Potent Modulator of Energy Metabolism.

Authors:  Rosalba Senese; Pieter de Lange; Giuseppe Petito; Maria Moreno; Fernando Goglia; Antonia Lanni
Journal:  Front Endocrinol (Lausanne)       Date:  2018-07-25       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.